Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined TFL and SSA for Photoaging
NCT06925035Completed
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Salvax in photoaging (2 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: photodamage score at 16 weeks. Started Jun 2023; status: completed.
02
Drugs
Salvax
03
Conditions
photoaging
Beyond the preview
Go deeper on NCT06925035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06925035.